Daily Roundup

PME.ASX SDF.ASX CCP.ASX GQG.ASX FPH.ASX

Pro Medicus Lands Major U.S. Healthcare Contract

Pro Medicus has secured a significant seven-year deal worth A$25 million with Valley Health, a Virginia-based health system operating six hospitals. The contract covers the company's Visage 7 imaging platform, including its viewer, workflow management, open archive, and cardiology imaging capabilities—all set to run on the cloud. Valley Health will migrate its legacy imaging archive to the new system and integrate images into its electronic health records, with rollout planned for Q1 2027. The transaction-based model offers additional upside potential, and the company notes growing interest in its broader "Full Stack +1" solution across all market segments.

Fisher & Paykel Healthcare Raises Guidance on Strong Performance

Medical device manufacturer Fisher & Paykel Healthcare is projecting robust growth ahead. For the first half of its 2027 financial year, the company expects revenue around $1.24 billion and net profit of approximately $280 million—representing 14% and 24% growth respectively compared to the prior-year period. Looking at the full year, management has updated its outlook to between $2.47 billion and $2.57 billion in revenue, with net profit expected between $525 million and $565 million. The company anticipates improved gross margins and is maintaining its assumptions around current global tariff policies.

Credit Corp Acquires HSBC Credit Card Portfolio

Credit Corp Group has signed a binding agreement to acquire HSBC's Australian credit card run-off book for approximately A$150 million, with completion expected in early 2027. The deal is subject to regulatory approval and will revise the company's FY27 guidance upwards. Credit Corp now projects PDL acquisitions between $300 million and $380 million, gross lending volumes of $445 million to $495 million, net profit after tax of $112 million to $120 million, and earnings per share of 164 to 176 cents. While the acquisition is expected to meet the company's hurdle returns, the receivables will have a shorter duration than typical for charged-off debt portfolios.

Steadfast Group Enters Takeover Agreement

Steadfast Group has entered into a Scheme Implementation Deed for its acquisition, with a bidder set to purchase all shares at $6.00 per share—a premium of 51.9% to the company's undisturbed closing price. Separately, Amwins Australasia will acquire Steadfast's underwriting agency business. The scheme is subject to regulatory and shareholder approvals, with implementation targeted for December 2026. The Steadfast board has recommended shareholders vote in favor. Trading in the stock has been halted pending the formal announcement, with resumption expected by August 25, 2026.

GQG Partners Reports Mixed Half-Year Results

Investment manager GQG Partners faced headwinds in the first half of 2026, experiencing net outflows of USD 15.1 billion despite investment performance gains of USD 7.2 billion. The company's funds under management totaled USD 156 billion as of June 30, with average FUM up 1.0% to USD 164.5 billion. Net revenue declined 1.4% to USD 397.2 million, while net operating income fell 1.7% to USD 301.8 million. The company declared a second-quarter dividend of USD 0.0362 per share, representing a 90% payout ratio of distributable earnings. Management fee revenue did increase 1.9% from the prior year, supported by higher average assets and improved fee realization rates.